多机构甲状腺超声注册研究中甲状腺风险分类系统与细针穿刺推荐比较
该研究基于ACR甲状腺超声注册中12208例患者27933个结节的前瞻性数据,回顾性比较ACR TI-RADS、ATA、K-TIRADS、EU-TIRADS及AI-TIRADS的FNA推荐率。结果显示ACR TI-RADS推荐FNA的结节比例为29.1%,低于ATA的58.7%、K-TIRADS的57.0%和EU-TIRADS的38.9%,而AI-TIRADS为26.3%。ACR TI-RADS因尺寸阈值和风险分级标准差异,较ATA、EU-TIRADS和K-TIRADS减少25%至50%的活检。
要点
- ACR TI-RADS的FNA推荐率(29.1%)显著低于ATA、K-TIRADS和EU-TIRADS,减少25%至50%的活检。
- TR3和TR4结节的FNA推荐率在ACR TI-RADS中最低,分别为18%和30%。
- 高可疑水平时各指南FNA率相似(68.7%至75.5%)。
局限性
- 回顾性分类可能引入偏倚。
- 研究人群为低风险成人患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to compare how often fine-needle aspiration (FNA) would be recommended for nodules in unselected, low-risk adult patients referred for sonographic evaluation of thyroid nodules by ACR Thyroid Imaging Reporting and Data System (TI-RADS), the American Thyroid Association guidelines (ATA), Korean Thyroid Imaging Reporting and Data System (K-TIRADS), European Thyroid Imaging Reporting and Data System (EU-TIRADS), and Artificial Intelligence Thyroid Imaging Reporting and Data System (AI-TIRADS).
METHODS: Seven practices prospectively submitted thyroid ultrasound reports on adult patients to the ACR Thyroid Imaging Research Registry between October 2018 and March 2020. Data were collected about the sonographic features of each nodule using a structured reporting template with fields for the five ACR TI-RADS ultrasound categories plus maximum nodule size. The nodules were also retrospectively categorized according to criteria from ACR TI-RADS, the ATA, K-TIRADS, EU-TIRADS, and AI-TIRADS to compare FNA recommendation rates.
RESULTS: For 27,933 nodules in 12,208 patients, ACR TI-RADS recommended FNA for 8,128 nodules (29.1%, 95% confidence interval [CI] 0.286-0.296). The ATA guidelines, EU-TIRADS, K-TIRADS, and AI-TIRADS would have recommended FNA for 16,385 (58.7%, 95% CI 0.581-0.592), 10,854 (38.9%, 95% CI 0.383-0.394), 15,917 (57.0%, 95% CI 0.564-0.576), and 7,342 (26.3%, 95% CI 0.258-0.268) nodules, respectively. Recommendation for FNA on TR3 and TR4 nodules was lowest for ACR TI-RADS at 18% and 30%, respectively. ACR TI-RADS categorized more nodules as TR2, which does not require FNA. At the high suspicion level, the FNA rate was similar for all guidelines at 68.7% to 75.5%.
CONCLUSION: ACR TI-RADS recommends 25% to 50% fewer biopsies compared with ATA, EU-TIRADS, and K-TIRADS because of differences in size thresholds and criteria for risk levels.
引用
- Hoang JK, Middleton WD, Langer JE, et al. Comparison of Thyroid Risk Categorization Systems and Fine-Needle Aspiration Recommendations in a Multi-Institutional Thyroid Ultrasound Registry. J Am Coll Radiol. 2021. PMID: 34419476. doi:10.1016/j.jacr.2021.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。